Geriatric Clinical Protocols

1980 ◽  
Vol 80 (12) ◽  
pp. 2275
Author(s):  
Janet A. Moli ◽  
Linda Joan Pearson ◽  
M. Ernestine Kotthoff
Keyword(s):  
Clinical Protocols

Auditory Dysfunction in Alzheimer's Disease

2010 ◽  
Vol 15 (1) ◽  
pp. 4-11 ◽  
Author(s):  
Sridhar Krishnamurti
Keyword(s):  
Alzheimer’S Disease ◽  
Older Adults ◽  
Alzheimer's Disease ◽  
Health Care ◽  
Care Setting ◽  
Neurodegenerative Disorder ◽  
Disease Process ◽  
Clinical Protocols ◽  
Speech Language Pathologist ◽  
Auditory Dysfunction

Alzheimer's disease is neurodegenerative disorder which affects a growing number of older adults every year. With an understanding of auditory dysfunction in Alzheimer's disease, the speech-language pathologist working in the health care setting can provide better service to these individuals. The pathophysiology of the disease process in Alzheimer's disease increases the likelihood of specific types of auditory deficits as opposed to others. This article will discuss the auditory deficits in Alzheimer's disease, their implications, and the value of clinical protocols for individuals with this disease.

"You have to do this, and only this": a plea for clinical flexibility at the time of coronavirus

2020 ◽  
Vol 14 (2) ◽  
pp. 214-226
Author(s):  
Adriano Bugliani
Keyword(s):  
Clinical Protocols ◽  
Special Circumstance ◽  
Emotional Closeness

The catastrophe of the coronavirus is just a special circumstance in order to show that clinical flexibility and a therapist's responsiveness is a necessary way of working if we want to meet our clients' very different situations and expressed needs. For decades a large amount of research has been stressing that "one size fits all" approaches are therapeutically detrimental, especially if clinical protocols are applied rigidly and exclusively. On the contrary, clinicians are helpful if they are able to tailor their craftsmanship to their clients' specific conditions, in particular by realising that emotional closeness can be attained even through phone or Skype.

Restorative dental treatment in times of COVID-19

2020 ◽  
Vol 68 ◽  
Author(s):  
Robson de Lima GOMES ◽  
Marlus da Silva PEDROSA ◽  
Claudio Heliomar Vicente da SILVA
Keyword(s):  
Severe Acute Respiratory Syndrome ◽  
Dental Treatment ◽  
Close Contact ◽  
Cross Contamination ◽  
Clinical Protocols ◽  
Know How ◽  
Dental Procedures ◽  
Dental Staff ◽  
Dental Professional ◽  
Restrictive Measures

ABSTRACT Since the outbreak of the Coronavirus Disease 2019 (COVID-19), caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), numerous restrictive measures have been adopted by governments of different countries. The return to elective dental care in Brazil is a reality even during the COVID-19 pandemic. During restorative dental procedures, the dental professional requires close contact with the patient, being exposed to contaminated saliva and fluids. In addition, transmission of COVID-19 by the generation of aerosol produced by dental handipieces may be possible. Thus, the dental staff must know how to act during restorative dental procedures, putting into practice the correct clinical protocols to avoid cross-contamination and COVID-19 spread. The purpose of this article is to review the literature on the biosafety practices especially in the context of restorative dental procedures in times of COVID-19.

scholarly journals Regenerative Endodontic Procedures: An Umbrella Review

2021 ◽  
Vol 18 (2) ◽  
pp. 754
Author(s):  
Luísa Bandeira Lopes ◽  
João Albernaz Neves ◽  
João Botelho ◽  
Vanessa Machado ◽  
José João Mendes
Keyword(s):  
Methodological Quality ◽  
Primary Outcome ◽  
Web Of Science ◽  
High Standard ◽  
Measurement Tool ◽  
Clinical Protocols ◽  
Umbrella Review ◽  
Electronic Database Search ◽  
Specific Section

The Regenerative Endodontic Procedure (REP) is a biologically based method in which a damaged pulp–dentin complex is replaced by a new vital tissue. This umbrella review aimed to critically assess the available systematic reviews (SRs) on REP. An electronic database search was conducted (PubMed-Medline, CENTRAL, Scielo, Web of Science, and LILACS) until December 2020. Studies were included if they were an SR on REP. The Risk of Bias (RoB) of SRs was analyzed using the Measurement Tool to Assess SRs criteria 2 (AMSTAR2). The primary outcome was the methodological quality in each specific section of REP protocols and outcomes. From 403 entries, 29 SRs were included. Regarding the methodological quality, ten studies were of critically low, three of low, fourteen of moderate, and two were rated as high quality. The quality of evidence produced by the available SRs was not favorable. Future high standard SRs and well-designed clinical trials are warranted to better elucidate the clinical protocols and outcomes of REP.

scholarly journals Implementing clinical protocols in oncology: quality gaps and the learning curve phenomenon

2005 ◽  
Vol 15 (4) ◽  
pp. 368-371 ◽  
Author(s):  
Simos Kedikoglou ◽  
Konstantinos Syrigos ◽  
Yannis Skalkidis ◽  
Fani Ploiarchopoulou ◽  
Nick Dessypris ◽  
...  
Keyword(s):  
Learning Curve ◽  
Clinical Protocols

scholarly journals Basic Knowledge Representation of Clinical Protocols for Translational Research

2005 ◽  
Vol 15 (2) ◽  
pp. 73-78
Author(s):  
Akira Sasaki ◽  
Jun Nakaya ◽  
Sayaka Kagekawa ◽  
Toshiyuki Tsukamoto ◽  
Takako Sakamoto ◽  
...  
Keyword(s):  
Knowledge Representation ◽  
Translational Research ◽  
Basic Knowledge ◽  
Clinical Protocols

scholarly journals Adjusting diet with sapropterin in phenylketonuria: what factors should be considered?

2011 ◽  
Vol 106 (2) ◽  
pp. 175-182 ◽  
Author(s):  
Anita MacDonald ◽  
Kirsten Ahring ◽  
Katharina Dokoupil ◽  
Hulya Gokmen-Ozel ◽  
Anna Maria Lammardo ◽  
...  
Keyword(s):  
Continuing Education ◽  
Nutritional Deficiencies ◽  
Dietary Management ◽  
Clinical Protocols ◽  
Restricted Diet ◽  
Mild Form ◽  
Adequate Nutrition ◽  
Blood Phenylalanine ◽  
Overweight Or Obesity

The usual treatment for phenylketonuria (PKU) is a phenylalanine-restricted diet. Following this diet is challenging, and long-term adherence (and hence metabolic control) is commonly poor. Patients with PKU (usually, but not exclusively, with a relatively mild form of the disorder) who are responsive to treatment with pharmacological doses of tetrahydrobiopterin (BH4) have either lower concentrations of blood phenylalanine or improved dietary phenylalanine tolerance. The availability of a registered formulation of BH4 (sapropterin dihydrochloride, Kuvan®) has raised many practical issues and new questions in the dietary management of these patients. Initially, patients and carers must understand clearly the likely benefits (and limitations) of sapropterin therapy. A minority of patients who respond to sapropterin are able to discontinue the phenylalanine-restricted diet completely, while others are able to relax the diet to some extent. Care is required when altering the phenylalanine-restricted diet, as this may have unintended nutritional consequences and must be undertaken with caution. New clinical protocols are required for managing any dietary change while maintaining control of blood phenylalanine, ensuring adequate nutrition and preventing nutritional deficiencies, overweight or obesity. An accurate initial evaluation of pre-sapropterin phenylalanine tolerance is essential, and the desired outcome from treatment with sapropterin (e.g. reduction in blood phenylalanine or relaxation in diet) must also be understood by the patient and carers from the outset. Continuing education and support will be required thereafter, with further adjustment of diet and sapropterin dosage as a young patient grows.

Sign in / Sign up

Export Citation Format

Share Document